New York, January 5, 2026, 11:35 EST — Regular session
Rocket Lab Corp shares slipped 0.7% to $75.43 by 11:09 a.m. EST on Monday, after closing at $75.99 on Friday. The stock traded between $71.31 and $75.70 and sits roughly 5% below its 52-week high of $79.83.
The wobble follows a sharp re-rating since Rocket Lab said it had won an $816 million prime contract from the U.S. Space Development Agency to design and manufacture 18 satellites for the agency’s Tracking Layer Tranche 3 program. The company said the award includes a $806 million base plus up to $10.45 million in options.
A Form 144 filing also drew attention after it showed Rocket Lab Chief Operating Officer Frank Klein planned to sell up to 100,000 shares under a Rule 10b5-1 trading plan. Form 144 is a notice insiders file before selling certain securities, while a 10b5-1 plan sets pre-arranged trades to reduce the risk of trading on non-public information.
The satellite award is part of the Pentagon’s push for proliferated constellations — large networks of smaller satellites — to improve missile warning and tracking. “The addition of these satellites will achieve near-continuous global coverage for missile warning and tracking,” said Gurpartap “GP” Sandhoo, the agency’s acting director, in a statement cited by the Los Angeles Business Journal, which also reported Lockheed Martin and Northrop Grumman were among other recipients in the broader tranche.
Cantor Fitzgerald on Monday reiterated an Overweight rating and a $72 price target on Rocket Lab, flagging the SDA win and what it sees as a heavy 2026 catalyst calendar. The broker said the contract about doubles Rocket Lab’s contracted backlog, which it put at roughly $1.1 billion as of the third quarter of 2025, and said the first flight of the company’s Neutron rocket is expected in the first half of 2026.
Rocket Lab last told investors it generated $155 million of revenue in the third quarter and forecast fourth-quarter revenue of $170 million to $180 million, with GAAP gross margin of 37% to 39%. It also updated the Neutron schedule, saying the rocket is set to arrive at its Launch Complex 3 site in the first quarter of 2026, with a first launch after that pending qualification testing and acceptance.
But the stock’s steep climb has amplified execution risk. Any slip in Neutron testing, slower conversion of backlog into booked revenue, or margin pressure from ramping production could sharpen drawdowns after a run that has pushed the shares near their highs.
Traders now look for follow-through on timing — and for the next set of numbers. Nasdaq’s earnings calendar estimates Rocket Lab will report next results around Feb. 26.
